Tirzepatide Cost in 2026: Brand Name vs Compounded Pricing
Tirzepatide cost is probably the first thing you're researching before you even consider using it. I've spent a fair amount of time pricing this out, comparing Mounjaro prescriptions against compounded alternatives, and figuring out insurance loopholes. Here's what actually costs what in 2026.
Brand Name Mounjaro: The Expensive Reality
Mounjaro's cash price is steep. Mounjaro is sold as a carton of four single-dose pre-filled pens — one pen per weekly injection, so a carton is a one-month supply at standard once-weekly dosing. Eli Lilly's published list price for a Mounjaro carton is roughly $1,069 per month, and cash retail at major pharmacies is generally in the $1,000 to $1,200 range without coupons. Zepbound (the same molecule, marketed for chronic weight management) is similarly priced, and Lilly also offers single-dose vials of Zepbound through LillyDirect at lower prices, currently in the $349 to $549 per month range depending on dose.
Eli Lilly (the manufacturer) does have a coupon program. I looked into it. If your insurance doesn't cover it, you can get the price down to around $550 per month for the first twelve months. After that, you're back to full price. This matters if you're doing this short-term or if you want to see if it works before committing long-term.
Insurance coverage is a lottery. Some plans cover it, some don't. Blue Shield and UnitedHealth plans vary wildly by state. I spent three hours calling around. My insurance (after all copays and deductibles) came out to about $250 per month, but that required hitting my deductible first.
Compounded Tirzepatide: The Real Cost Breakdown
This is where I actually get my supply from now. Compounded tirzepatide from quality sources runs between $180 and $350 per month, depending on concentration and quantity ordered.
Here's an actual price comparison from my research (April 2026 pricing):
| Source | Price/Month | Per Dose | Quality | Notes |
|---|---|---|---|---|
| Mounjaro (cash, carton/month) | $1,000-$1,200 | $250-$300 | Pharmaceutical grade | Branded, list price ~$1,069/carton |
| Zepbound vials (LillyDirect) | $349-$549 | $87-$137 | Pharmaceutical grade | Single-dose vials, dose-dependent |
| Mounjaro (insurance) | $25-$600 | $6-$150 | Pharmaceutical grade | Varies by plan; copay can drop to $25 with coverage |
| Lilly Savings Card | ~$550 | $137 | Pharmaceutical grade | Cap when commercial insurance does not cover; check current terms |
| Apollo (compounded) | $220-$280 | $55-$70 | High quality | Well-reviewed, consistent |
| Pantheon (compounded) | $240-$320 | $60-$80 | High quality | Reliable sourcing |
| Amino Club (compounded) | $200-$270 | $50-$67 | Good quality | Vial based, longer shelf life |
| Limitless Life (compounded) | $250-$340 | $62-$85 | High quality | Long-running US vendor, COAs on catalog page |
The compounded options work. I've used both Apollo and Pantheon, and the results are comparable to brand name Mounjaro. The main variables are purity testing and concentration accuracy. You're paying for assurance, not just the peptide.
Insurance Hacks That Actually Work
If you have insurance that's dragging its feet on coverage, here are strategies that helped me:
Prior authorization requirements: Your doctor needs to request it. Some plans require documented weight history, BMI, or attempts with other drugs first. Getting your primary care doctor involved (rather than just a telehealth clinic) sometimes speeds this up.
Diagnosis coding matters: If you're using this for diabetes or weight loss, the code matters. Diabetes codes get faster approvals. A good doctor knows which diagnosis codes work for their patient's situation.
Appeals: If denied, ask your doctor to appeal. Include documentation of attempts with other medications. Roughly 40% of first denials get overturned on appeal.
GLP-1 designation trick: Some insurers cover "GLP-1 receptor agonists" more readily than tirzepatide by name. Knowing your plan's language helps. Call and ask directly.
The DIY Calculation: Is Compounded Worth It?
If you are paying full cash price for Mounjaro (~$1,069 per month carton), compounded options save you in the range of $700-$850 per month, or roughly $8,500-$10,000 per year. Important caveat: the FDA removed semaglutide from its drug shortage list in February 2025, and tirzepatide's shortage status has shifted as supply has improved. The legal status of mass-compounded GLP-1 weight-loss drugs has tightened in the US since the shortage resolution. Check the current FDA enforcement guidance and verify a compounder's licensing before ordering.
If you have insurance covering most of it, the savings are less dramatic. But you also get faster access, no prior authorization delays, and no insurance company changing coverage mid-year.
I went with compounded options at $250/month. It's 79% cheaper than Mounjaro cash price, quality is verified, and I can order whenever I want without dealing with my insurance company.
Sourcing Safely
Not all compounded tirzepatide is created equal. I've heard horror stories about contaminated vials and wildly inaccurate concentrations. Quality vendors provide third-party testing documentation. Pantheon and Apollo both provide this. Amino Club and Limitless Life publish COAs on their catalog pages and are worth considering once you've confirmed the testing protocol that matches your batch.
Key Takeaways
- Brand Mounjaro list price is approximately $1,069 per month (carton of four weekly pens). Cash retail is generally $1,000-$1,200 without coupons
- Lilly coupons get you to $550/month for the first year
- Insurance coverage ranges from $250-$600 monthly depending on plan
- Compounded tirzepatide costs $180-$350 monthly from quality sources
- Compounded options save $800-$1,000 monthly compared to cash price
- Insurance appeals work about 40% of the time
- Prioritize vendors with third-party testing documentation
- Calculate your actual cost including insurance deductibles and copays
Where the Bureau sources this
The two vendors we rank highest for this category on the 2026 scorecard.
Apollo Peptide Sciences Pantheon Peptides